Forcare Clinical Research Inc

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)	Plaque Psoriasis	Active, not recruiting	Phase 3	2026-09-28	NCT06220604
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis	Plaque Psoriasis	Active, not recruiting	Phase 3	2026-09-28	NCT06143878
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis	Plaque Psoriasis	Active, not recruiting	Phase 3	2026-09-28	NCT06095115
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis	Plaque Psoriasis	Active, not recruiting	Phase 3	2026-09-25	NCT06934226
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)	Plaque Psoriasis	Active, not recruiting	Phase 3	2026-09-25	NCT06095102

Clinical trials